Aileron Therapeutics, Inc. (ALRN) — Financial statements
Income statement, balance sheet, and cash flow for Aileron Therapeutics, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00↓100.0% | 0.12↓29.6% | 0.17↑39.7% | 0.12 | |
| Gross Profit | 0.00 | 0.00↑100.0% | -0.12↑29.6% | -0.17↓39.7% | -0.12 | |
| Operating Expenses | ||||||
| R&D Expenses | 11↓22.6% | 14↑257.0% | 4↓77.8% | 18↑5.6% | 17 | |
| General & Administrative Expenses | 11↓21.4% | 14↑22.1% | 11↑17.3% | 10↑0.9% | 10 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 11↓21.4% | 14↑22.1% | 11↑17.3% | 10↑0.9% | 10 | |
| Other Expenses | 29↓22.4% | 37↑3887.1% | 0.93 | 0.00 | 0.00 | |
| Operating Expenses | 51↓22.2% | 65↑300.0% | 16↓41.1% | 28↑3.9% | 27 | |
| Total Costs & Expenses | 0.00 | 0.00↓100.0% | 16↓41.1% | 28↑3.9% | 27 | |
| Operating Results | ||||||
| Operating Income | -51↑22.2% | -65↓300.0% | -16↑41.1% | -28↓3.9% | -27 | |
| Depreciation & Amortization | 0.00 | 0.00↓100.0% | 0.12↓29.6% | 0.17↑39.7% | 0.12 | |
| EBITDA | -51↑22.2% | -65↓317.0% | -16↑43.2% | -27↓3.8% | -26 | |
| EBIT | 0.00 | 0.00↑100.0% | -16↑43.1% | -28↓3.9% | -27 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00↑100.0% | -0.54 | 0.00 | 0.00 | |
| Other Income / Expenses | 0.76↓65.9% | 2↑309.7% | 0.54↑71.1% | 0.32↓27.9% | 0.44 | |
| Income Before Tax | -50↑20.7% | -63↓299.7% | -16↑42.4% | -27↓4.3% | -26 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00↑100.0% | -0.44 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -50 | 0.00↑100.0% | -16↑42.4% | -27↓4.5% | -26 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -50↑20.7% | -63↓299.7% | -16↑41.8% | -27↓4.8% | -26 | |
| Bottom-Line Net Income | -50↑20.7% | -63↓299.7% | -16↑42.4% | -27↓4.5% | -26 | |
| EPS (Basic) | -1.96↑44.2% | -3.51↓2.6% | -3.42↑42.5% | -5.95↓2.6% | -5.80 | |
| EPS (Diluted) | -1.96↑44.2% | -3.51↓2.6% | -3.42↑42.5% | -5.95↓2.6% | -5.80 | |
| Weighted Average Shares | 25↑41.8% | 18↑290.1% | 5↑1.3% | 5↑2.2% | 4 | |
| Weighted Average Diluted Shares | 25↑41.8% | 18↑290.1% | 5↑1.3% | 5↑2.2% | 4 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.